Targeting the RXR pathway for the prevention of triple-negative breast cancer HHSN2612015000181 task order 9
Ended Awarded Last action
- Contract number
- 75N91018F00008
- Awardee
-
The Univeristy Of Texas M.d. Anderson Cancer Center UEI S3GMKS8ELA16 Part of University Of Texas System
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $774,513
Award facts
- Opportunity
-
- N01CN5500347 Solicitation number
- Preclinical PREVENT Cancer Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers Award Notice · Posted Sep 25, 2015
- Preclinical PREVENT Cancer Program for Preclinical Efficacy and Intermediate Endpoint Biomarkers Award Notice · Posted Jan 5, 2015
- Contract value 100% obligated
- $774,513.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Houston, TX 77030, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | -$3,876 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $778,389 |
About this award
This is a delivery order awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to The University of Texas MD Anderson Cancer Center, a component of the University of Texas System. The award is part of the PREVENT Cancer Program (PREVENT), which supports preclinical research on preventing triple-negative breast cancer. The $774,513.14 firm-fixed-price task order covers research targeted at the RXR pathway for the prevention of triple-negative breast cancer. This work is being conducted at MD Anderson's facilities in Houston, Texas. The contract does not have a set-aside designation.
Quick answers
Who was awarded contract 75N91018F00008?
75N91018F00008 was awarded to The Univeristy Of Texas M.d. Anderson Cancer Center by National Cancer Institute (National Institutes of Health) on September 17, 2018.
How much is contract 75N91018F00008 worth?
The government has obligated $774,513 on 75N91018F00008.
Is contract 75N91018F00008 an order under another contract?
Yes. 75N91018F00008 is a delivery order under HHSN261201500018I, an indefinite delivery contract, on PREVENT Cancer Program (PREVENT).
Was contract 75N91018F00008 competed?
The extent of competition for 75N91018F00008 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award